Skip to content

Development studies of electronic patient's diary to improve pharmacist's CINV countermeasure (pre-trial)

Development studies of electronic patient's diary to improve pharmacist's CINV countermeasure (pre-trial) - Development studies of electronic patient's diary to improve pharmacist's CINV countermeasure (pre-trial)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000028908
Enrollment
20
Registered
2017-08-30
Start date
2017-09-10
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

CINV chemotherapy induced nausea and vomiting

Interventions

Have the CINV symptom input for 7 days by using electronic patient&#39

Sponsors

Tokyo University of Science
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.patients undergoing hospitalization or outpatient chemotherapy 2.Patient who is 20 years old or more and can enter smartphone or personal computer 3.Patient who signed, based on his/her free will, to the clinical trial agreement with full understanding of the purpose of this conducted trial and its insights

Exclusion criteria

Exclusion criteria: 1.Patients who may cause substrate or functional nausea / vomiting such as gastrointestinal transit disorder, brain metastasis, electrolyte abnormality, uremia, etc. 2.patients using emetic drugs in combination 3.patients taking antipsychotics with antiemetic actions, antiemetics and steroids on a regular basis 4.pregnant 5.judged by the investigator to be inappropriate for this study

Design outcomes

Primary

MeasureTime frame
Improvement of electronic patient's diary

Countries

Japan

Contacts

Public ContactMasayo Komoda

Tokyo University of Science Faculty of Pharmaceutical Sciences

komo1207@rs.noda.tus.ac.jp04-7121-4134

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026